<DOC>
	<DOCNO>NCT01406782</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This research study study DNA isolate blood sample see well influence response rituximab patient follicular lymphoma treat clinical trial ECOG-E4402 .</brief_summary>
	<brief_title>DNA Analysis Influencing Response Rituximab Samples From Patients With Follicular Lymphoma Treated ECOG-E4402</brief_title>
	<detailed_description>OBJECTIVES : - To test influence killer immunoglobulin-like receptor ( KIR ) human lymphocyte antigen ( HLA ) genotype response anti-CD20 antibody lymphoma immunotherapy . OUTLINE : DNA sample analyze killer immunoglobulin-like receptor ( KIR ) human lymphocyte antigen ( HLA ) genotyping sequence-specific primer ( SSP ) real-time PCR . KIR HLA type analyzed accord KIR-HLA match v mismatch , KIR B haplotype content , number inhibitory KIR-HLA pair . Results correlate patient 's overall response duration response rituximab .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Follicular</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients diagnose follicular lymphoma enrol ECOGE4402 Treated singleagent rituximab ; trial compare two different rituximabdosing strategy maintenance v retreatment need Available germline DNA sample isolate peripheral blood well clinical evaluation disease status prior initial response therapy PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
</DOC>